Wednesday 3 April 2019

A 'low dose aspirin' for dementia? Drug ready for first in-human testing

Alzheimer's disease wreaks emotional havoc on patients, who are robbed of their memories, their dignity, and their lives. It's financially devastating as well: care for Alzheimer's patients is predicted to top $1 trillion by about the time children born today are having children of their own.

* This article was originally published here